We are live on ! Find out more
Kinnevik

Kinnevik Portfolio holdings

AUM $65.6M Turnover 0%
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68M
AUM Growth
-$3.09M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.5 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.81B
$68M 100%
13,434,171
– –
2022 Q4
10 quarters

Similar funds

Kinnevik's Q2 2025 Portfolio in Review

As of Q2 2025, Kinnevik held 1 position worth $68M, down 4.3% from $71.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Kinnevik opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kinnevik's ten largest holdings make up 100% of its $68M portfolio in Q2 2025.
  • Kinnevik opened 0 new positions and closed 0 in Q2 2025.
  • Kinnevik's portfolio value fell 4.3% quarter-over-quarter to $68M.

Based on Kinnevik's 13F filing for Q2 2025, filed 13 Aug 2025.